Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial-Reference-Cited by-同舟云学术

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial

Published:2023-08 Issue: Volume:31 Page:100672
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Sapoval Marc^ORCID,Thiounn Nicolas^ORCID,Descazeaud Aurélien,Déan Carole^ORCID,Ruffion Alain,Pagnoux Gaële,Duarte Ricardo Codas,Robert Grégoire,Petitpierre Francois,Karsenty Gilles,Vidal Vincent,Murez Thibaut,Vernhet-Kovacsik Hélène,de la Taille Alexandre,Kobeiter Hicham,Mathieu Romain,Heautot Jean-Francois,Droupy Stéphane,Frandon Julien,Barry Delongchamps Nicolas,Korb-Savoldelli Virginie,Durand-Zaleski Isabelle,Pereira Helena,Chatellier Gilles,Pellerin Olivier,Sabatier Brigitte,Dariane Charles,Gabay Benjamin,Moldovan Paul Cezar,Rouvière Olivier,Champagnac Jean,Lagabrielle Samuel,Grenier Nicolas,Boissier Romain,Lechevallier Éric,Izaaryene Jalal-Jean,Tradi Farouk,Arrouasse Raphaele,Defontaines Julien,Joseph Xavier,Le Corvoisier Philippe,Sbidian Emilie,Champy Cécile,Chiaradia Mélanie,Chevrot Armand,Blion Cyrille,Goupil Jean,Bulsei Julie,Vappereau Alexandra

Funder

Merit Medical Systems

Ministère des Affaires Sociales et de la Santé

French Government Ministry of Social Affairs Health and Womens Rights

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference30 articles.

1. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being;Eckhardt;J Urol,2001

2. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia;Barry;Urology,2001

3. EAU guidelines on non neurogenic LUTS including benign prostatic obstruction;Cornu,2023